CV6 Therapeutics

Menu
  • About Us
  • Science
  • Pipeline
  • Partnerships
  • News
  • Contact Us

About Us

  • Our Company
  • Management
  • Board of Directors
  • Scientific Advisors
  • R&D Team
  • Careers

Management

CV6 Therapeutics’ management team brings together decades of experience across both science and business disciplines.

Richard Milliken, CA
Chairman, Chief Financial Officer

Robert D. Ladner, PhD
Founder, Chief Executive Officer

Karl A. Mulligan, PhD
Co-Founder, Chief Operating Officer

Peter M. Wilson, PhD
Scientific Director of Drug Development

CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel combination therapies

  • CV6 Therapeutics - Early stage drug development company
  •  
  • European Union - European Regional Development Fund - Investing in your future.

© 2025 CV6 Therapeutics (NI) Ltd. All rights reserved.

Website by Pale Blue Dot

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

CV6 Therapeutics
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.